
|
|
|
|
|
Kids with Cancer Foundation's enormously generous donation of $500,000 in 2003 to Australia's first stem cell facility, the "Sydney Cord Blood Bank", greatly assisted with the capital funding needed to open this facility, without your donation there would be no Stem Cell Facility (Sydney Cord Blood Bank).
Thanks to that support the Sydney Children’s Hospital, Randwick has established Australia’s first Stem Cell facility dedicated to the treatment of children’s diseases. Through the innovative use of non-embryonic stem cells, the Hospital will lead the world in the treatment of children’s cancer. Your contribution has enabled us to build this new facility. We are extremely grateful for the opportunity you have allowed CCC&BD to pave the way forward in this innovative treatment (Sydney Children's Hospital).
Over 850 stem cell transplants were performed at Sydney Children's Hospital (to 2012) making it the oldest and largest paediatric program in Australasia. The program has nationally lead the way having performed the first cord transplant, first double cord transplant and boasts the longest surviving transplant recipient in the Southern Hemisphere.
Stem transplant is often the only curative option for paediatric patients with high risk or relapsed cancers and for many non-malignant diseases including immunedeficiency disorders, marrow failure, metabolic diseases and thalassemia.
Our research team has a broad portfolio aimed at improving successful outcomes through preclinical and clinical initiatives. Specific barriers including engraftment, infection, graft versus host disease, supportive care, relapse, quality standards and medication safety are key areas ofongoing research.
Recently as part of our 2017, $446,000 donation to the Kids Cancer Centre (KCC) at Sydney Children’s Hospital, Kids with Cancer Foundation agreed to fund a new position in the KCC, ‘The Kids with Cancer Foundation Bone Marrow Transplant Fellow’. Dr. Vasant Chinnabhandar is the new BMT Fellow.
In the first year of the fellowship alone, the new Bone-Marrow Transplant Fellow will teach up to 80 medical staff and have over 75,000 touch points of contact with patients. Training the next generation of specialist paediatric haematologist and oncologists and researchers is essential to the provision of future cancer care for children in Australia.
Kids with Cancer Foundation's enormously generous donation of $500,000 in 2003 to Australia's first stem cell facility, the "Sydney Cord Blood Bank", greatly assisted with the capital funding needed to open this facility. Through the innovative use of non-embryonic stem cells, the Hospital will lead the world in the treatment of children's cancer. Your signification contribution will assist the Hospital conduct crucial research in this area which we hope will mean less time in Hospital for transplant patients, less infection, lower cost and most importantly, improved survival rates for these brave children.
Every year 350 children in NSW are diagnosed with some form of cancer or blood disorder. Bone Marrow and Stem Cell transplants now play a major role in the treatment of cancer and other blood disorders, in particular leukaemia. Produced within the bone marrow, stem cells are valuable in fighting diseases, because of their ability to regenerate the immune system.
Only fifty percent of patients find compatible bone marrow donors from their immediate or extended family or in bone marrow donor registries. The remaining fifty percent of patients must find a suitable unrelated donor in Cord Blood Banks.
One of the greatest risks for any transplant patient is the treatment required prior to the transplant when the patient’s marrow stops producing white cells, red cells and platelets. This period places the patient at life threatening risks of anaemia, haemorrhages and infections. Children who have a bone marrow transplant need multiple blood transfusions, antibiotic therapy and will suffer from painful mouth ulcers during the more than two week period it takes for the new marrow to regrow after the transplant.
Innovations:
The Australian Stem Cell Facility will provide the following groundbreaking initiatives:
All this means less time in hospital, less infection, less supportive treatment, lower cost and most importantly, improved survival rates for these brave children
Our research team has a broad portfolio aimed at improving successful outcomes through preclinical and clinical initiatives. Specific barriers including engraftment, infection, graft versus host disease, supportive care, relapse, quality standards and medication safety are key areas ofongoing research.
Further we have active funded research in law and ethics of decision making around stem cell transplantation and cord blood and educational initiatives to improve understanding for parents, patients and education staff. Professor Glenn Marshall AM
What is Cord blood & how is it used
Cord Blood is the blood remaining in the umbilical cord and placenta after delivery of the baby and after the umbilical cord is cut. This blood has provided the baby with nutrition while in the womb but after birth is no longer needed and would normally be discarded. It is collected from the umbilical cord vein in an average volume of about 90mL. This collection is performed without disturbing the normal delivery practice and is therefore not harmful to the mother and baby.
The cord blood is rich in blood stem cells. These stem cells are the building blocks for blood cells. They are normally found in the bone marrow, which can perpetually produce the blood cells found in the circulating blood (white cells, red blood cells and platelets). Cord blood can be frozen and stored (banked) for over 20 years without loss of potency to the blood stem cells. Cord blood is therefore an alternative source of blood stem cells to bone marrow.
Bone marrow transplantation is a curative treatment for many otherwise fatal diseases such as cancer (including leukaemia and lymphoma), immune deficiency, aplastic anaemia and thalassaemia. The problem is the bone marrow donor has to be compatible and the white cells rigorously matched in their tissue type (the equivalent to ABO blood groups on red cells). Only about half the patients needing a bone marrow transplant can find a suitable compatible donor. Cord blood stem cells do not need such rigorous matching, making cord blood a versatile option for stem cell transplant.
During the past 25 years, over 10,000 cord blood transplants have been undertaken in both children and adults. Initially cord blood transplants were performed as a last resort for patients where there was no compatible bone marrow donor and the patients would have died without a transplant. However, there were survivors, and now, over 25 years later, and with increasing experience, it is clear that cord blood transplantation is not a last resort treatment but an alternative to bone marrow, and in many situations the preferred option.
Cord Blood Transplant is a curative treatment for diseases such as:
• Immune deficiency
• Acute and chronic leukaemia's
• Some haematological malignancies
• Blood diseases such as Aplastic and Fanconi Anaemia
• Metabolic Storage diseases
• Thalassaemia
More diseases are being treated with Cord Blood Transplant. Consult your Haematologist or Oncologist for additional information.
https://www.schn.health.nsw.gov.au/parents-and-carers/our-services/sydney-cord-blood-bank
Free-call 1800 255522
Phone (02) 9680 7444
Fax. (02) 9680 7544
E-mail This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it.
PO Box 7000, Baulkham Hills BC NSW 2145
Copyright © 2012 Kids with Cancer Foundation
Please read our Privacy Policy
Supported by Concise IT Engineering